CorriXR Therapeutics
Latest round
- Seed
Last raised
- Jun 2022
Total raised
- $2.5M
Investors
- 3
About CorriXR Therapeutics
Based in Delaware, US, and founded in 2022, CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative research-based biotechnology company. The company was founded by its CEO Eric B Kmiec. In August 2025, CorriXR Therapeutics received 1 million from Delaware.
Who invested in CorriXR Therapeutics
3 investors across 1 round
See all investors in CorriXR Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 30, 2022
Amount
$2.5M
Investors
Questions about CorriXR Therapeutics
Who invested in CorriXR Therapeutics?
CorriXR Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CorriXR Therapeutics raised?
CorriXR Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CorriXR Therapeutics last raise money?
CorriXR Therapeutics's most recent round on record is a Seed, in Jun 2022.
What does CorriXR Therapeutics do?
Based in Delaware, US, and founded in 2022, CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative research-based biotechnology company.
Where is CorriXR Therapeutics headquartered?
CorriXR Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like CorriXR Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CorriXR Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CorriXR Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.